tiprankstipranks
NRX Pharmaceuticals (NRXP)
NASDAQ:NRXP
US Market
NRXP
NRX Pharmaceuticals
RESEARCH TOOLSreports
Want to see NRXP full AI Analyst Report?

NRX Pharmaceuticals (NRXP) Ratios

880 Followers

NRX Pharmaceuticals Ratios

NRXP's free cash flow for Q4 2025 was $0.48. For the 2025 fiscal year, NRXP's free cash flow was decreased by $ and operating cash flow was $-4.67. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Mar 24Dec 22
Liquidity Ratios
Current Ratio
 0.31 0.31 0.15 0.36 1.66
Quick Ratio
 0.31 0.31 0.15 0.36 1.66
Cash Ratio
 0.27 0.27 0.07 0.24 1.29
Solvency Ratio
 -0.99 -0.99 -0.93 -1.58 -2.16
Operating Cash Flow Ratio
 -0.49 -0.49 -0.49 -1.14 -2.55
Short-Term Operating Cash Flow Coverage
 -44.66 -44.66 -6.79 -2.36 -5.16
Net Current Asset Value
$ -20.00M$ -20.00M$ -23.57M$ -12.16M$ 7.39M
Leverage Ratios
Debt-to-Assets Ratio
 0.05 0.05 1.80 1.25 0.41
Debt-to-Equity Ratio
 -0.04 -0.04 -0.28 -0.78 1.42
Debt-to-Capital Ratio
 -0.04 -0.04 -0.40 -3.56 0.59
Long-Term Debt-to-Capital Ratio
 0.00 -0.02 -0.28 0.00 0.28
Financial Leverage Ratio
 -0.81 -0.81 -0.16 -0.62 3.48
Debt Service Coverage Ratio
 -33.87 -16.26 -9.09 -3.24 -5.16
Interest Coverage Ratio
 -24.14 -24.18 -18.26 -229.89 0.00
Debt to Market Cap
 <0.01 0.01 0.28 0.26 0.01
Interest Debt Per Share
 0.04 0.06 0.73 1.23 0.16
Net Debt to EBITDA
 0.21 0.45 -0.21 -0.15 0.24
Profitability Margins
Gross Profit Margin
50.61%47.10%0.00%0.00%0.00%
EBIT Margin
-2740.98%-1321.47%0.00%0.00%0.00%
EBITDA Margin
-2729.31%-1309.80%0.00%0.00%0.00%
Operating Profit Margin
-1322.04%-1324.41%0.00%0.00%0.00%
Pretax Profit Margin
-2336.57%-2336.49%0.00%0.00%0.00%
Net Profit Margin
-2336.57%-2336.49%0.00%0.00%0.00%
Continuous Operations Profit Margin
-2336.57%-2336.49%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
176.74%176.42%127.52%109.29%89.67%
Return on Assets (ROA)
-220.92%-220.92%-688.20%-412.17%-153.99%
Return on Equity (ROE)
111.73%179.59%108.19%256.97%-536.56%
Return on Capital Employed (ROCE)
103.67%103.85%108.19%235.12%-433.34%
Return on Invested Capital (ROIC)
105.81%106.00%118.37%1072.59%-247.21%
Return on Tangible Assets
-279.58%-279.57%-688.20%-412.17%-153.99%
Earnings Yield
-30.07%-49.35%-108.59%-86.51%-5.45%
Efficiency Ratios
Receivables Turnover
 7.61 7.61 0.00 0.00 0.00
Payables Turnover
 0.14 0.15 <0.01 <0.01 <0.01
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 1.76 1.94 0.00 0.00 0.00
Asset Turnover
 0.09 0.09 0.00 0.00 0.00
Working Capital Turnover Ratio
 -0.05 -0.06 0.00 0.00 0.00
Cash Conversion Cycle
 -2.53K -2.36K -301.49K -338.14K -189.44K
Days of Sales Outstanding
 47.97 47.97 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 2.58K 2.41K 301.49K 338.14K 189.44K
Operating Cycle
 47.97 47.97 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.44 -0.66 -1.01 -2.86 -0.60
Free Cash Flow Per Share
 -0.44 -0.66 -1.01 -2.86 -0.60
CapEx Per Share
 0.00 0.00 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 0.00 -7.22K -3.98K
Capital Expenditure Coverage Ratio
 0.00 0.00 0.00 -7.22K -3.98K
Operating Cash Flow Coverage Ratio
 -22.36 -22.36 -1.62 -2.36 -3.78
Operating Cash Flow to Sales Ratio
 -11.52 -11.52 0.00 0.00 0.00
Free Cash Flow Yield
-27.21%-24.33%-45.97%-62.15%-5.45%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -3.33 -2.03 -0.92 -1.16 -18.36
Price-to-Sales (P/S) Ratio
 42.40 47.35 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 -5.98 -3.64 -1.00 -2.97 98.53
Price-to-Free Cash Flow (P/FCF) Ratio
 -3.68 -4.11 -2.18 -1.61 -18.36
Price-to-Operating Cash Flow Ratio
 -6.76 -4.11 -2.18 -1.61 -18.36
Price-to-Earnings Growth (PEG) Ratio
 -0.10 0.05 0.02 >-0.01 0.20
Price-to-Fair Value
 -5.98 -3.64 -1.00 -2.97 98.53
Enterprise Value Multiple
 -1.34 -3.17 -1.18 -1.31 -18.13
Enterprise Value
 44.69M 50.83M 28.27M 39.42M 720.48M
EV to EBITDA
 -1.34 -3.17 -1.18 -1.31 -18.13
EV to Sales
 36.48 41.50 0.00 0.00 0.00
EV to Free Cash Flow
 -3.17 -3.60 -2.66 -1.82 -18.12
EV to Operating Cash Flow
 -3.17 -3.60 -2.66 -1.82 -18.12
Tangible Book Value Per Share
 -0.59 -0.87 -2.21 -1.55 0.11
Shareholders’ Equity Per Share
 -0.50 -0.74 -2.21 -1.55 0.11
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.04 0.06 0.00 0.00 0.00
Net Income Per Share
 -0.90 -1.34 -2.39 -3.98 -0.60
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.85 1.77 1.04 1.00 1.00
Research & Development to Revenue
 3.08 3.08 0.00 0.00 0.00
SG&A to Revenue
 10.62 10.66 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.13 0.19 0.00 0.00 0.00
Income Quality
 0.49 0.49 0.42 0.72 1.00
Currency in USD